0001415889-21-001176.txt : 20210302 0001415889-21-001176.hdr.sgml : 20210302 20210302182834 ACCESSION NUMBER: 0001415889-21-001176 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210226 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lampropoulos Justin J. CENTRAL INDEX KEY: 0001643609 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18592 FILM NUMBER: 21705875 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000856982 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870447695 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 WEST MERIT PARK WAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 8012531600 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 4 1 form4-03022021_030315.xml X0306 4 2021-02-26 0000856982 MERIT MEDICAL SYSTEMS INC MMSI 0001643609 Lampropoulos Justin J. 1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095 false true false false PRESIDENT, EMEA Common Stock, No Par Value 2021-02-26 4 A 0 3315 0 A 3315 D Common Stock, No Par Value 2021-02-26 4 F 0 972 55.72 D 2343 D Non-qualified stock options (right to buy) 12.06 2015-10-04 2021-10-04 Common Stock 5000 5000 D Non-qualified stock options (right to buy) 17.27 2016-02-13 2022-02-13 Common Stock 20000 20000 D Non-qualified stock options (right to buy) 16.05 2017-01-28 2023-01-28 Common Stock 20000 20000 D Non-qualified stock options (right to buy) 28.20 2018-04-14 2024-04-14 Common Stock 25000 25000 D Non-qualified stock options (right to buy) 44.80 2019-03-02 2025-03-02 Common Stock 20000 20000 D Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 30000 30000 D Non-qualified stock options (right to buy) 37.71 2021-02-26 2027-02-26 Common Stock 16722 16722 D These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. The number of securities underlying these stock options was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct. The number of securities beneficially owned was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct. Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016. Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017. Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018 Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019. Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020. Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021. /s/ Brian G. Lloyd, Attorney-in-Fact 2021-03-02